Oral Ganciclovir for Patients with Cytomegalovirus Retinitis Treated with a Ganciclovir Implant
Daniel Martín(University of Leeds), Charles A. Robinson(Center for Global Development), Richard A. Wolitz(Kaiser Permanente San Francisco Medical Center), Alan G. Palestine(University of Colorado System), Hong Li(Henan Agricultural University), Baruch D. Kuppermann(University of California, Irvine)
Cited by 485
Related Papers
Sjögren's syndrome. Proposed criteria for classification
|Arthritis & Rheumatism|1986|685
Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients
|The Lancet|1997|501
A Controlled Trial of Valganciclovir as Induction Therapy for Cytomegalovirus Retinitis
|New England Journal of Medicine|2002|394
Valganciclovir Results in Improved Oral Absorption of Ganciclovir in Liver Transplant Recipients
|Antimicrobial Agents and Chemotherapy|2000|363
Transfer of human systemic lupus erythematosus in severe combined immunodeficient (SCID) mice.
|The Journal of Experimental Medicine|1990|153